General Information of Drug (ID: DMVA8KU)

Drug Name
ASP0113 Drug Info
Synonyms VCL-CB01
Indication
Disease Entry ICD 11 Status REF
Cytomegalovirus infection 1D82 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DMVA8KU

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cytomegalovirus Deoxyribonucleic acid (CMV DNA) TTK938H NOUNIPROTAC Not Available [2]

References

1 ClinicalTrials.gov (NCT01877655) A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT). U.S. National Institutes of Health.
2 VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection. Curr Opin Mol Ther. 2009 Oct;11(5):572-8.